{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-002729","form_type":"8-K","ticker":"PRLD","cik":"0001678660","company_name":"Prelude Therapeutics Inc","filed_at":"2023-02-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.106783+00:00","generated_at":"2026-06-19T14:05:11.328001+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Prelude Therapeutics posts investor presentation for SVB Global Biopharma Conference","bullets":["Filed investor presentation under Regulation FD for Feb 2023 SVB conference.","Presentation attached as Exhibit 99.1 with no specific financial or clinical details in filing body.","No new material events, guidance changes, or operational updates disclosed in the 8-K text."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-002729","json":"https://secwatch.observer/filing/0000950170-23-002729.json","markdown":"https://secwatch.observer/filing/0000950170-23-002729.md","text":"https://secwatch.observer/filing/0000950170-23-002729.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1678660/000095017023002729/0000950170-23-002729-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1678660/000095017023002729/prld-20230214.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T14:05:11.328001+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}